INTRODUCTION
Three morphologically distinct types of cell death occur in physiologic and pathologic processes: apoptosis, autophagy, and necrosis (Edinger and Thompson, 2004) . p53 is a critical transcriptional activator and exerts additional biochemical functions in the cytoplasm. In its central role as cellular stress sensor that responds to a myriad of signals including DNA damage, oxidative stress and ischemia, p53 controls programs of apoptosis via transcription-dependent and -independent mechanisms to limit the propagation of damaged cells. p53-controlled apoptosis involves transcriptional induction of components of the death receptor and mitochondrial pathways including CD95, Puma, Noxa, Bax, and others, which cooperatively promote cell death (Brady et al., 2011; Riley et al., 2008) . In addition, p53 protein can directly promote mitochondrial outer membrane permeabilization (MOMP) to trigger apoptosis by modulating the MOMP governing Bcl-2 family (Green and Kroemer, 2009; Vaseva and Moll, 2009) . We and others previously identified a p53 protein-based mitochondrial apoptosis program. Upon stress, a cytoplasmic pool of p53 rapidly translocates to the mitochondrial surface, where it physically interacts with both anti-and proapoptotic Bcl-2 family members to inhibit or activate their respective functions, leading to MOMP and apoptosis. In this role, p53 acts like a BH3-only protein, either as direct activator of the Bax/Bak effectors, or as sensitizer/ derepressor of Bcl-xL/2 and Mcl1 (Vaseva and Moll, 2009) . While in principle the proapoptotic effects of cytoplasmic p53 are not dependent on transcription by nuclear p53, the latter appears to enhance the function of cytoplasmic p53.
p53 also has a complex role in regulating autophagy which can promote either cell survival under stress or cell death, dependent on context. Activated nuclear p53 can transcriptionally induce AMPK and sestrin1/2 with subsequent mTOR inhibition and autophagy. Autophagy can promote cell death when apoptosis is compromised, or act as reinforcement of apoptotic caspase signaling. The overlap between apoptosis and autophagy in p53-activated cell death is illustrated by the p53 target genes DRAM, Bax, and Puma, also shown to be positive autophagy regulators. Conversely, basal levels of p53 in the cytoplasm can directly inhibit autophagosomes (Vousden and Ryan, 2009) .
Necrosis is the irreversible tissue destruction due to bioenergetic failure, and central to ischemia/reperfusion injury and oxidative damage as occurs in cerebral stroke and myocardial infarction. The fundamental difference to apoptosis is the rapid loss of cellular membrane potentials due to energy depletion and ion pump/channel failures, leading to swelling, rupture, and cytolysis. Mediators of necrosis are excess cytosolic Ca 2+ and ROS levels. Rather than being a passive event, necrosis has emerged as a controlled cell death that induces an inflammatory response to stimulate tissue repair by selectively releasing factors like HMGB1 and HDGF from dying cells (Zong and Thompson, 2006) . Necrosis in ischemic tissues, which is experimentally modeled by H 2 O 2 treatment of cultured cells, depends on cyclophilin D (CypD), the key regulator of the mitochondrial permeability transition pore (PTP) at the inner membrane whose opening leads to cell death (Halestrap, 2006) . As shown by four independent strains, CypD À/À mice are resistant to ischemia-induced necrosis in myocardial infarction and stroke, and CypD-deficient mitochondria and cells are resistant to Ca 2+ and H 2 O 2 -induced cell death. But notably, they remain sensitive to Bcl-2 family-driven apoptosis, emphasizing the two functionally distinct mitochondrial death systems (Baines et al., 2005; Basso et al., 2005; Nakagawa et al., 2005; Schinzel et al., 2005) . PTP is a regulated nonselective waterand solute-passing protein channel spanning the inner (IMM) and outer (OMM) mitochondrial membranes at points of contact. The identity of the actual pore-forming proteins of PTP are still debated, since they appear in part dispensable (Baines, 2010) but can encompass VDAC (voltage-dependent anion channel) across the OMM, and ANT (adenine nucleotide translocase) across the IMM. In contrast, the prolyl isomerase CypD in the mitochondrial matrix is the essential regulator of the PTP pore opening, and the only genetically proven indispensable PTP component (Kroemer et al., 2007) . H + pumping out of the matrix creates the proton gradient DJm across the IMM necessary to maintain mitochondrial respiration and ATP production. In unstressed cells, PTP is closed and the IMM impermeable to ions. Upon oxidative stress, sudden PTP opening causes massive ion influx that dissipates DJm and shuts down oxidative phosphorylation and ATP production. This is called mitochondrial permeability transition (mPT). Concomitantly, water influx causes matrix swelling, rupture of the rigid OMM and release of all sequestered cell death factors. mPT is triggered by mitochondrial matrix sequestration of high levels of cytosolic Ca 2+ and ROS generated during oxidative damage. Clinically, CypD-triggered PTP opening and mPT is the driving pathophysiological force behind cerebral stroke, myocardial infarction and other vascular catastrophies that are leading causes of death. How CypD becomes activated to induce mPT remains unclear but depends on its prolyl isomerase activity. Cyclosporine A (CsA) potently and specifically prevents mPT by binding to CypD, inhibiting its isomerase activity and displacing it from the PTP (Kroemer et al., 2007) .
It is currently unknown whether p53 can also activate oxidative stress-induced necrosis. Intriguingly, our findings provide genetic, biochemical and pharmacological evidence that fundamentally expands our understanding of p53-mediated cell death networks into necrosis. We identify an unexpected critical role of stress-accumulated mitochondrial p53 protein in directly regulating PTP at the inner membrane. Upon oxidative stress, p53 triggers PTP opening by engaging in a physical interaction with CypD, thereby inducing necrotic cell death in mouse and human cells. Importantly, this pathway is implicated in brain ischemiareperfusion injury.
RESULTS
In Addition to Bax/Bak Lipid Pores, Purified p53 Also Engages PTP to Induce Mitochondrial Membrane Permeabilization We previously showed in isolated mitochondria that purified p53 causes robust cytochrome C (CytoC) release by inducing Bak oligomerization and MOMP with the same efficiency as tBid (Mihara et al., 2003; Wolff et al., 2008) . Moreover, we showed that p53 is able to release the entire gamut of soluble and nonsoluble apoptogenic factors including noncleaved apoptosisinducing factor (AIF) and Endo G that are tethered to the IMM by severely disrupting both outer and inner mitochondrial membrane integrity. In contrast, tBid is restricted to releasing only soluble components via MOMP (Wolff et al., 2008) . This suggests a stronger permeabilizing effect by p53 than by the prototypical activator of the Bax/Bak pore, tBid. Thus, we hypothesized that p53 is capable of recruiting additional BH3-independent pathways of mitochondrial permeabilization.
To this end, we compared the release response of isolated WT and Bax/Bak double-knockout (DKO) mitochondria (Figure S1A available online) toward highly purified recombinant p53 and tBid. Bax/Bak DKO cells are deprived of the apoptotic gateway to mediate CytoC release for caspase activation (Kim et al., 2006) . Indeed, p53 was able to rapidly release CytoC, Smac (soluble), and AIF (membrane tethered) from both WT and Bax/ Bak DKO mitochondria, while the tBid-induced release was restricted to WT mitochondria ( Figure 1A ). The strict Bax/Bakdependence of tBid-mediated MOMP is completely consistent with the notion of tBid as direct activator of the Bax/Bak lipid pore, tBid's sole target (Kuwana et al., 2005) . In contrast, p53 apparently has additional mitochondrial targets to mediate mitochondrial permeabilization.
We reasoned that p53 might also engage the mitochondrial PTP pore. To look for evidence of p53-induced functional alterations of this pore, we used the fluorescent dye calcein, a highly selective indicator of sustained PTP opening in situ (Kroemer et al., 2007) . MOMP and the Bax/Bak lipid pore are completely incompetent for calcein release (Petronilli et al., 1998) . Adding increasing doses of purified p53 to calcein-prelabeled WT or Bax/Bak DKO mitochondria resulted in a rapid and almost complete loss of signal, indicating PTP opening. In contrast, even the highest dose of tBid lacked any effect ( Figure 1B and Figure S1B ). Moreover, p53 but not tBid induced structural alterations of PTP components. WT mouse liver mitochondria were incubated with increasing amounts of purified p53 prior to chemical crosslinking. VDAC-containing complexes ranging from $60-300 kDa were readily detected in control mitochondria incubated with buffer or BSA but increasingly disappeared upon addition of p53 in a dose-dependent fashion ( Figure 1C and Figure S1C ). Thus, p53 was able to drive VDAC into high molecular weight complexes that no longer entered the gel. This activity was unique to p53, since tBid had no effect on VDAC oligomerization ( Figure 1D ). Moreover, p53 but not tBid was able to induce swelling (another classical hallmark of PTP opening) of Bax/Bak DKO and WT mitochondria in a CsA-dependent ( Figure 1E ) and CypD-dependent ( Figures 1F and 1G ) manner. Thus, in addition to the Bax/Bak lipid pore, p53 can also engage the PTP pore to induce mitochondrial membrane permeabilization. complex. Since both p53 and mPT play important roles during oxidative stress (Gudkov and Komarova, 2010; Halestrap, 2006; Vaseva and Moll, 2009) , we looked for an interaction between p53 and the PTP components CypD, ANT, and VDAC upon H 2 O 2 treatment. Immunoprecipitation detected a prominent oxidative stress-induced endogenous complex between p53 and the essential regulatory PTP component CypD (Figure 2A) . No interaction was seen between p53 and the proposed structural components VDAC and ANT (Figure 2A ). The H 2 O 2 -inducible specific p53-CypD complex was confirmed with pull-down assays of HA-tagged CypD, VDAC, and ANT expressed in cells with endogenous p53 ( Figure 2B ). Moreover, endogenous mitochondrial p53 binds to recombinant glutathione S-transferase (GST)-CypD in a CsA-dependent manner ( Figure 2C ). Finally, cell-free pull-down experiments with recombinant proteins confirmed the direct CsA-sensitive interaction ( Figure 2D ). Mapping experiments with a series of p53 deletion mutants identified p53 amino acids 80-220 as the region required for CypD interaction ( Figure 2E and Figures S2A-S2C).
While we failed to identify a single specific subregion, the p53 contact domains that are required for Bcl-xL/Bcl-2 interaction (designated with ''D'') (Mihara et al., 2003) were not required for CypD binding ( Figure S2D ), underlining structural differences between the two types of interactions. Tetrameric p53 is the preferred partner for CypD interaction ( Figure 2F ), while it is debated whether mitochondrial p53 that directly triggers Bcl-2 family-mediated apoptosis at the OMM acts as monomer or tetramer (Heyne et al., 2008; Pietsch et al., 2007) .
Rapid Stabilization and Mitochondrial Translocation of p53 upon Oxidative Stress
Next, we asked whether p53 accumulates in mitochondria upon oxidative stress. Treating various wtp53 harboring cell lines and primary MEFs with 0.25-0.75 mM H 2 O 2 uniformly induced robust cellular p53 stabilization ( Figure 3A ). This oxidative stressinduced p53 response was fast, reaching its peak within 1 hr in most cells ( Figure 3B ). Immunofluorescence staining of C6 rat glioma cells treated with H 2 O 2 for 4 hr showed primarily punctate perinuclear p53 accumulation, confirming earlier findings (Bonini et al., 2004) , which colocalized with CypD in mitochondria. This suggests an important mitochondrial function of the p53 protein within this window of time during oxidative stress ( Figure 3C ). Moreover, using sucrose gradient ultracentrifugation, p53 accumulated in mitochondria that were free of detectable contamination within 4 hr of H 2 O 2 treatment ( Figure 3D ). Importantly, subsequent submitochondrial fractionation of this mitochondrial starting material ( Figure S3A ) confirmed that during oxidative stress a fraction of p53 accumulated in the matrix where CypD is located, while some also localized to the surface, as expected ( Figure 3E ). The observed p53 fractions in the mitochondrial intermembranous space and inner membrane likely represent transport intermediates to the matrix. Moreover, H 2 O 2 -induced mitochondrial p53 was also partially protected from trypsin digestion in classical import assays ( Figure S3B ) and import of p53 required a mitochondrial membrane potential ( Figure S3C ). This is in agreement with hypoxia-induced endogenous complexes between p53 and the major matrix import proteins mtHSP70 and mtHSP60 ( Figure S3D ), which we had also reported earlier (Sansome et al., 2001) . Of note, the endogenous p53 that accumulates in the mitochondrial matrix is detectable by immunogold electron microscopy (see table in Figure S3E ).
Oxidative Stress Induces Mitochondrial Permeability Transition in a p53-Dependent Manner CypD-regulated mPT is a crucial event during H 2 O 2 -induced cell death, definitively established by the CypD knockout mice. Our initial results in isolated mitochondria had shown that purified p53 protein was able to engage PTP in a CypD-dependent manner ( Figure 1 ). However, an mPT-regulatory role of p53 in vivo remained to be established. We therefore asked whether H 2 O 2 -induced PTP opening in cells is p53 dependent.
Opening of the PTP pore and subsequent mPT results in dissipation of the mitochondrial membrane potential DJm across the IMM. The cationic fluorescent dye tetramethylrhodamine methyl ester (TMRM) is widely used to assess changes in DJm and mPT. TMRM is readily sequestered by healthy mitochondria, but its fluorescence is rapidly lost when DJm is dissipated. S4B ). This strong p53-dependent response was also observed in the isogenic HCT116 p53 +/+ and p53 À/À pair ( Figure S4C ). These results were further confirmed by direct in situ assessment of PTP pore opening via Calcein release, which again showed p53 and CypD dependence (see CsA, Figures 4D and 4E and Figure S4D ). Of note, while CsA can block other cytosolic cyclophilins besides mitochondrial matrix-specific CypD, none of them play any role in mitochondrial mPT. In sum, the mPT-regulatory activity of p53 in cells in response to oxidative stress is also CypD dependent. In contrast, p53 does not respond to calcium overload, and calcium overload-induced PTP opening and necrosis does not require p53 ( Figures S4E-S4H ).
Oxidative Stress Induces Necrosis that Concomitantly Depends on p53 and CypD Both necrosis and apoptosis are oxidative stress-induced cell death modes (Javadov and Karmazyn, 2007) . Upon oxidative stress, CypD primarily mediates necrotic death via PTP and mPT (Baines et al., 2005; Nakagawa et al., 2005) , and evidence exists that CypD can actively suppress apoptosis (Eliseev et al., Li et al., 2004; Machida et al., 2006) . On the other hand, while p53 protein is a well-established apoptosis regulator, almost nothing is known if and when p53 participates in regulating necrotic cell death. Importantly, primary p53-deficient MEFs were equally well protected from H 2 O 2 -induced cell death as CypD-deficient MEFs, while 60% of WT MEFs died, as indicated by cell viability assays measuring metabolic activity and membrane integrity ( Figure 5A ). To determine the nature of this cell death we first measured apoptosis. Notably, only negligible TUNEL positivity was detected in all genotypes and H 2 O 2 conditions used ( Figure 5B ). Thus, upon oxidative stress the protection of primary MEFs bestowed by loss of p53 and CypD, and conversely the death of WT MEFs, is largely unrelated to apoptosis. Instead, electron microscopy of H 2 O 2 -treated WT MEFs revealed all signatures of necrosis, such as loss of plasma membrane integrity, organelle swelling, massive intracellular vacuoles, and lack of nuclear fragmentation ( Figure 5C and Figure S5A) . The same holds true for cancer cells, as shown by the HCT116 p53 +/+ and p53 À/À colorectal carcinoma pair ( Figure 5D ). Figure S3 .
Lack of p53 or silencing of CypD by shRNA (see Figure S5B ) caused significant resistance to H 2 O 2 -induced cell death, while 50% of WT cells were killed. On the other hand, a similar rescue effect was obtained by eliminating/silencing p53 alone or together with CypD, i.e., p53 was epistatic to CypD, further supporting that they act on the same biochemical pathway. Again, apoptosis levels in HCT116 p53 +/+ cells were very low (10%), confirmed by the complete absence of cleaved PARP induction (Figure 5E) , and did not account for the observed 50% of cell death ( Figure 5D ). Instead, H 2 O 2 -treated cells released large quantities of High Mobility Group Box 1 (HMGB1) protein into the culture medium in a dose-dependent, p53-dependent, and CypD-dependent manner ( Figure 5E , right). Released HMGB1 is the classical biochemical hallmark specific for necrosis. In contrast, in apoptotic cells HMGB1 binds irreversibly to the condensed chromatin in the nucleus (Bianchi and Manfredi, 2004) . While stabilization of p53 alone was sufficient to induce p53 accumulation at mitochondria, it was not sufficient to induce PTP opening in the absence of oxidative stress ( Figure S5C ). In sum, these data indicated that the predominant mode of cell death in response to H 2 O 2 was p53/CypD-mediated necrotic cell death. Moreover, in addition to camptothecininduced apoptosis ( Figure 5E , left), Camptothecin also triggered some necrosis, as indicated by HMGB1 release that was p53 and CypD dependent ( Figure S5D ). This is consistent with the observed camptothecin-induced p53-CypD complex ( Figure 2C ). 
Direct Targeting of p53 to the Mitochondrial Matrix Induces mPT and Necrosis in a CypD-Dependent
Manner; Oxidative Stress-Induced PTP Opening and Necrosis Are Largely Transcription Independent Although the above data strongly suggest a direct necrosisregulating action of p53 at the mitochondria, oxidative stress also induces p53 target genes, some of which might contribute to regulate the observed H 2 O 2 response in a CypD-dependent manner. For example, proteins participating in pro-or antioxidation that modulate cellular ROS levels are transcriptional p53 targets (Hussain et al., 2004; Macip et al., 2003; Sablina et al., 2005) . Thus, direct proof was necessary to substantiate the local action of mitochondrial p53, as opposed to its nuclear action.
To this end we first used direct targeting of p53 to the mitochondrial matrix. We had previously generated various mito- Figure S5 .
chondrially targeted versions of wildtype p53 (Mihara et al., 2003) . One of them, called Lp53 (wt p53 fused to the mitochondrial import leader sequence of ornithine transcarbamylase) delivers p53 specifically and exclusively to the mitochondrial matrix, where the leader sequence gets cleaved off (Mihara et al., 2003) ( Figure 6A left and Figure S6A ). Importantly, Lp53 completely bypasses the nucleus and is devoid of any transcriptional activities (Mihara et al., 2003) . Indeed, adenoviral delivery of Lp53 into the mitochondrial matrix caused a major loss of DJm in WT MEFs, indicated by loss of TMRM fluorescence. In contrast, Lp53 had no effect in CypD À/À MEFs ( Figure 6A right) . This indicates that p53 in the mitochondrial matrix can regulate PTP opening in cells independent of p53 transcription. This direct p53 action requires CypD. Moreover, PFTa, an inhibitor of p53-mediated transcription, or a-amanitin, a powerful general transcriptional inhibitor of RNA Polymerase II, did not significantly prevent oxidative stress-induced PTP opening or cell death in WT MEFs ( Figure 6B and Figures S6B and S6C Figures S6D-S6F) . Again, robust p53-and CypDdependent HMGB1 release into the medium ( Figure 6C ) and lack of significant apoptosis ( Figure 6D ) confirmed the primarily necrotic nature of the cell death.
To further support the role of mitochondrial p53 in oxidative stress-induced necrotic death, we used Bax/Bak DKO MEFs. Adenovirally delivered Lp53 in Bax/Bak DKO MEFs localized to mitochondria ( Figure S6G ) and importantly, bound to endogenous CypD ( Figure S6H ). As already seen for WT MEFs (Figure 6C) , Lp53 greatly sensitized DKO cells to oxidative stress at early time points, and this sensitivity was abolished upon CypD knockdown ( Figure 6E and Figure S6I ). Cell death was again due to necrosis and not apoptosis, as indicated by HMGB1 release that depended on the presence of CypD, as well as the absence of Casp3 and PARP cleavage ( Figure 6F and Figure S6J ). In sum, the physical interaction between mitochondrial p53 and CypD is critical to induce necrotic cell death upon oxidative stress. This p53 action is independent of Bax and Bak.
Pathologic p53-CypD Complex Formation during Ischemic Stroke-Induced Brain Tissue Necrosis
In vivo, the parameters required for induction of mPT are fulfilled during stroke (transient ischemia-reperfusion injury of the brain). During brain ischemia, the absence of glucose and oxygen causes mitochondrial dysfunction, intracellular calcium uptake and a sharp decrease in ATP levels. Subsequent brain reperfusion generates the conditions required for mPT as mitochondria repolarize, sequester excess cytosolic calcium accumulated during the ischemic period, and generate ROS and oxidative stress. Cells (mainly neurons but also glia) die largely by necrosis, although in the peripheral penumbra apoptosis also takes place. Importantly, CypD deficiency confers significant protection against ischemic brain injury in permanent and transient ischemic stroke models in mice (Schinzel et al., 2005) .
Since our cell culture data identified a physical and functional interaction between mitochondrial p53 and CypD that is critical for oxidative stress-induced necrosis, we investigated the pathophysiologic role of the PTP-regulating function of p53 in transient ischemia/reperfusion stroke. To this end, WT, p53 +/À , and WT control mice pretreated with CsA were subjected to carefully controlled unilateral acute middle cerebral artery occlusion (MCAO) for 1 hr, followed by 24 hr of reperfusion. Infarct size was measured by staining coronal brain slices with triphenyl-tetrazolium chloride (TTC), a dye that is oxidized by intact mitochondrial dehydrogenase to yield the red product formazan. In the infarcted area (white), mitochondria are uncoupled and dysfunctional and no longer stain with TTC. WT brains (n = 8) were grossly infarcted. Intriguingly, p53 +/À brains (n = 8) were strongly protected from stroke, similar to WT control mice protected by intraperitoneal injection of CsA 15 min prior to MCAO (n = 6) ( Figures 7A and 7B ). Most importantly, a pathologic p53-CypD complex was robustly induced in infarcted WT brains after MCAO, as shown by coimmunoprecipitation with a specific p53 antibody but not with IgG ( Figure 7C , 'MCAO'). Intriguingly, the induced p53-CypD complex was undetectable in CsA-pretreated, stroke-protected WT control mice. Moreover, the complex was only barely detectable in p53 +/À mice, whose stroke stress-mediated p53 induction did not exceed the baseline p53 levels of WT control mice, and which were also strongly protected from infarction ( Figure 7C ). Thus, a strong association exists between the formation of the pathologic p53-cypD complex and ischemia-reperfusion brain infarction. These data support the idea that this p53-CypD axis is an important pathophysiologic contributor to ischemic stroke.
DISCUSSION
Here, we identify a new role of p53 in activating necrotic cell death. In response to oxidative stress and ischemia, p53 protein accumulates in the mitochondrial matrix and triggers PTP opening, mPT and necrosis by physical interaction with the critical PTP regulator CypD. This p53 action is transcription-independent and inhibited by the specific CypD inhibitor CsA, and by genetic CypD deletion or knockdown. In support, in contrast to the prototypical MOMP-inducer tBid, purified p53 protein has efficacy that goes beyond activating the Bax/Bak lipid pore at the outer membrane. p53 is able to also rapidly open the PTP pore at the inner membrane in healthy Bax
dria where tBid fails. Similarly, p53 causes structural alterations of the PTP pore, while tBid does not. Using gene knockout and knockdown in mouse and human cells, we show that oxidative stress induces PTP opening, mPT and necrosis that concomitantly depend on the presence of p53 and CypD. Importantly, WT, Bax/Bak DKO and p53 À/À cells are all (further) sensitized to H 2 O 2 -induced PTP opening and necrotic death upon direct delivery of p53 into the mitochondrial matrix. This sensitivity is reversed by knockdown of CypD, confirming the physiological p53-CypD crosstalk. Most intriguingly, a robust p53-CypD complex is formed during necrosis in brain tissue upon ischemia/reperfusion stroke injury. In contrast, genetic reduction of p53 levels (p53 +/À mice) or CsA pretreatment of WT mice prevents this complex from forming, and is associated with effective stroke protection. This strongly supports a pathophysiologic role of the mitochondrial p53-CypD axis in ischemic stroke.
Aside from p53, very few extramitochondrial proteins are known to bind CypD and trigger pathologic PTP opening. A compelling analogy to p53, albeit acting chronically, is the highly toxic, soluble intracellular form of b amyloid peptide (Ab), a key protein in Alzheimer's disease (AD) that progressively (E and accumulates in brain mitochondria of AD patients and AD transgenic mice. In AD, Ab forms a critical complex with CypD that promotes PTP opening, thereby boosting Ca 2+ -induced mitochondrial damage and neuronal injury. Inhibiting PTP or ablating CypD in AD mice renders their cortical brain mitochondria resistant to PTP opening and improves their cognitive functions (Du et al., 2008) .
In response to many insults, a continuum of apoptosis and necrosis exists. Such insults induce apoptosis at lower doses and necrosis at higher doses, a scenario that is clearly the case in ischemic brain infarction with an apoptotic penumbra surrounding a necrotic center (Zong and Thompson, 2006) . The long-standing paradigm had been that p53 controls apoptosis but plays no role in necrosis. Only recently the very first link between p53 and necrosis was reported. Upon etoposide-mediated DNA damage Bax/Bak DKO MEFs die via slow necrosis, which is largely controlled by p53-mediated transcription of cathepsin Q in cooperation with DNA damageinduced ROS (Tu et al., 2009) . Interestingly, however, this transcriptional p53-cathepsin Q axis only plays a minor role in the corresponding WT MEF necrosis. In contrast, H 2 O 2 -induced necrosis in DKO MEFs was found to be completely transcription independent (Tu et al., 2009) , supporting our finding of direct CypD-mediated necrotic signaling by p53. Thus, in response to oxidative stress our data establish a necrotic mitochondrial p53 program, in addition to the well-characterized mitochondrion-based apoptotic p53 program. The decision of whether to engage one and/or the other appears to depend on the type and dose of stress. Clearly though, necrotic signaling also uses p53-independent pathways, depending on the insult. Examples are necrosis induced by DNA alkylating agents which signals through PARP and necrosis signaling via the TNFR/RIP1 pathway (Zong and Thompson, 2006) .
In oxidative damage, our data show that p53 can control a CypD-mediated necrotic program in various cell types in vitro and in brain tissue in vivo. The surprisingly strong brain protection of p53 +/À mice from ischemia/reperfusion injury ( Figures   7A and 7B ) is likely due to two components: The absence of a destructive p53-CypD complex, thereby protecting the PTP pore ( Figure 7C ), and the presence of an only weak p53 apoptosis program such as e.g., Puma and Noxa ( Figure S7A ). Importantly though, the absence of the p53-CypD complex appears to be the dominant factor in stroke protection. This is indicated by CsA-protected WT brains that do not form the p53-CypD complex, yet concomitantly mount a full-blown p53 apoptosis program including Puma and Noxa ( Figure S7A ). Conversely, p53 À/À MEFs but not Puma À/À MEFs are protected from oxidative stress-induced cell death, confirming that Puma does not play a significant role in this process ( Figure S7B ). Parenthetically, the p53 homolog p73, which is robustly expressed in adult mouse and human brain, was not induced in the ischemic brain tissues ( Figure S7C ). Finally, although low or uninduced levels of p53 can clearly mount a transcriptional antioxidant defense by regulating expression of, e.g., sestrins, glutathione peroxidase and TIGAR, this is highly tissue specific. Notably, in brain tissue p53 is constitutively pro-oxidant in both physiologic and pathologic conditions due to transcriptional repression of antioxidant genes (Chatoo et al., 2009 (Crumrine et al., 1994) . CypD À/À mice show strong protection against focal ischemiareperfusion brain injury (Schinzel et al., 2005) . Similarly, mice and rats treated with CsA or nonimmunosuppressive derivatives that do not bind to calcineurin are also protected from stroke (Khaspekov et al., 1999; Korde et al., 2007; Matsumoto et al., 1999) . Clinically, CsA is chronically given to organ transplant patients as a time-tested immunosuppressant. Our data suggest that acute temporary blockade of the destructive p53-CypD complex by CsA-type inhibitors may be a therapeutic strategy to limit infarct extent in the rising number of ischemic stroke patients where reperfusion of the occluded artery can be reestablished by interventional thrombolysis.
EXPERIMENTAL PROCEDURES
Cell Culture Primary WT and p53 À/À mouse embryo fibroblasts (MEFs) were established from E13.5 embryos. Primary CypD À/À MEFs were purchased (ArtisOptimus).
Bax/Bak DKO and corresponding WT MEFs were a gift of Dr. Weixing Zong, Stony Brook Univ. MEFs (all SV40 immortalized) and cancer cell lines were maintained in DMEM/10% FBS. Cyclosporine A, a-amanitin, Pifithrin-a, ionomycin, and FCCP were purchased from Sigma.
Plasmids and Recombinant Proteins pGEX-CypD were a gift from Dr. Dario Altieri, University of Massachusetts (Kang et al., 2007) . Human cypD, ANT-2 and VDAC-1 cDNAs in pHA vectors were gifts from Dr. Stefan Grimm, Max-Planck-Institute, Germany (Bauer et al., 1999) . Immunoaffinity purified recombinant human p53 expressed in human cells was purchased (Origene). Recombinant adenovirus (Ad5-GFP) was generated as described previously under the control of a CMV promoter. Luc shRNA and CypD shRNA plasmids were purchased (Dharmacon).
Mitochondrial Isolation
Mitochondria from cultured cells and mouse liver were isolated by sucrose gradients as we described (Mihara et al., 2003) . Mitochondria (35 mg) were subjected to chemical crosslinking with BMH (1,6-bis-maleimidohexane, Pierce, 10 mM in dimethyl sulfoxide [DMSO] for 10 min) or mock treated (DMSO only). Submitochondrial fractionation was performed by phosphate swellingshrinking as described (Kang et al., 2007) and detailed in the Supplemental Information. For mitochondrial assays, see also Supplemental Information.
Biochemical Assays
For immunoprecipitation, isolated mitochondria or cells were lysed in PBS containing 1% Triton X-100 and protease inhibitors (Roche). After centrifugation at 13,000 3 g for 10 min at 4 C, the supernatant was precleared with Protein G-agarose beads (Roche) for 2 hr at 4 C, and 500 mg of precleared protein extracts were incubated with antibody to p53 or CypD for 16 hr at 4 C. Precipitated complexes were washed in lysis buffer and bound proteins analyzed by immunoblots. For GST pull-down experiments, bead -bound GST-CypD was blocked with H-buffer (20 mM HEPES pH 7.7, 75 mM KCl, 0.1 mM EDTA, 2.5 mM MgCl 2 , 0.05% NP40, 1 mM DTT, 1 mg/ml BSA). Blocked beads were incubated with cell/mitochondria lysates or recombinant proteins for 16 hr at 4 C in the presence of 5 mM CsA or vehicle. Pelleted beads were washed in H-buffer and bound proteins analyzed by immunoblots. For HA-pull down assays, HA-antibody (Abcam) was used to precipitate protein complexes from cells expressing HA-tagged CypD, VDAC or ANT.
Cell Death Assays
Cell viability was assessed by Cell Titer Blue (CTB) and Trypan Blue Exclusion assays (Sigma). Apoptosis was measured by TUNEL (TMR Red Kit, Roche). Nuclei were counterstained with Hoechst 33342. Apoptosis was quantified as the proportion of red/blue areas from three representative images (Zeiss Axioskope with AxioVision v4.3).
HMGB1 Release Assay
Medium from treated cells was harvested, spun at 800 3 g for 5 min and supernatant filtered (0.45 mm). Proteins were precipitated with trichloroacetic acid and analyzed by HMGB1 immunoblots. 
